SUSMED,Inc. (4263) Stock Statistics & Valuation Metrics

SUSMED,Inc. has a market cap or net worth of ¥6.66B. The enterprise value is ¥10.92B.

SUSMED,Inc. has 16,868,100 shares outstanding. The number of shares has decreased by -2.65% in one year.

SUSMED,Inc.’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -8.11%.

The current PE Ratio of SUSMED,Inc. is ―. SUSMED,Inc.’s PEG ratio is -1.37.

In the last 12 months, SUSMED,Inc. had revenue of 497.21M and earned -382.69M in profits. Earnings per share was -22.71.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

SUSMED,Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

SUSMED,Inc. upcoming earnings date is Nov 6, 2026, TBA (Confirmed).

SUSMED,Inc. as a current ratio of 27.40, with Debt / Equity ratio of 0.00%

In the past 12 months, SUSMED,Inc. has paid 3.80M in taxes.

SUSMED,Inc. EV to EBITDA ratio is -34.09, with an EV/FCF ratio of -19.89.

SUSMED,Inc. has ¥3.70B in cash and marketable securities with ¥0.00 in debt, giving a net cash position of ¥3.70B billion.

Gross margin is 96.50%, with operating margin of -66.40%, and net profit margin of -76.97%.

The average price target for SUSMED,Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―